Table 2.

Correlations between Change from Baseline to Week 28 (QLS, CGI-S, WoRQ, TooL, SWN-S) or Scores at Week 28 (IAQ, CGI-I) by Treatment

Correlation EstimatesQLS TotalCGI-SIAQ TotalCGI-IWoRQ TotalTooL Total
AOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PP
CGI-S-0.598-0.381
IAQ-total-0.587-0.5100.3920.473
CGI-I-0.459-0.4000.7650.7150.4590.578
WoRQ-total-0.322-0.3960.4680.2360.2600.1810.3800.333
TooL total-0.374-0.3650.3230.2130.3550.0580.4910.1680.117-0.158
SWN-S total0.3750.376-0.390-0.355-0.330-0.259-0.260-0.348-0.113-0.064-0.689-0.557
Correlation EstimatesQLS TotalCGI-SIAQ TotalCGI-IWoRQ TotalTooL Total
AOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PP
CGI-S-0.598-0.381
IAQ-total-0.587-0.5100.3920.473
CGI-I-0.459-0.4000.7650.7150.4590.578
WoRQ-total-0.322-0.3960.4680.2360.2600.1810.3800.333
TooL total-0.374-0.3650.3230.2130.3550.0580.4910.1680.117-0.158
SWN-S total0.3750.376-0.390-0.355-0.330-0.259-0.260-0.348-0.113-0.064-0.689-0.557

Analyzed posthoc at patient level with MMRM to assess partial correlations between scales in the full analysis set. Abbreviations: CGI-I, Clinical Global Impression–Improvement; CGI-S, CGI–Severity; IAQ, Investigators’ Assessment Questionnaire; MMRM, mixed model for repeated measures; QLS, Heinrichs-Carpenter Quality of Life Scale; SWN-S, Subjective Well-Being Under Neuroleptic Treatment−short version; Tool, Tolerability and Quality of Life Questionnaire; WoRQ, Work Readiness Questionnaire.

Higher QLS and SWN-S total scores indicate clinical improvements, whereas lower CGI-S, IAQ, CGI-I, WoRQ, and TooL scores indicate better clinical condition.

Table 2.

Correlations between Change from Baseline to Week 28 (QLS, CGI-S, WoRQ, TooL, SWN-S) or Scores at Week 28 (IAQ, CGI-I) by Treatment

Correlation EstimatesQLS TotalCGI-SIAQ TotalCGI-IWoRQ TotalTooL Total
AOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PP
CGI-S-0.598-0.381
IAQ-total-0.587-0.5100.3920.473
CGI-I-0.459-0.4000.7650.7150.4590.578
WoRQ-total-0.322-0.3960.4680.2360.2600.1810.3800.333
TooL total-0.374-0.3650.3230.2130.3550.0580.4910.1680.117-0.158
SWN-S total0.3750.376-0.390-0.355-0.330-0.259-0.260-0.348-0.113-0.064-0.689-0.557
Correlation EstimatesQLS TotalCGI-SIAQ TotalCGI-IWoRQ TotalTooL Total
AOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PPAOM 400PP
CGI-S-0.598-0.381
IAQ-total-0.587-0.5100.3920.473
CGI-I-0.459-0.4000.7650.7150.4590.578
WoRQ-total-0.322-0.3960.4680.2360.2600.1810.3800.333
TooL total-0.374-0.3650.3230.2130.3550.0580.4910.1680.117-0.158
SWN-S total0.3750.376-0.390-0.355-0.330-0.259-0.260-0.348-0.113-0.064-0.689-0.557

Analyzed posthoc at patient level with MMRM to assess partial correlations between scales in the full analysis set. Abbreviations: CGI-I, Clinical Global Impression–Improvement; CGI-S, CGI–Severity; IAQ, Investigators’ Assessment Questionnaire; MMRM, mixed model for repeated measures; QLS, Heinrichs-Carpenter Quality of Life Scale; SWN-S, Subjective Well-Being Under Neuroleptic Treatment−short version; Tool, Tolerability and Quality of Life Questionnaire; WoRQ, Work Readiness Questionnaire.

Higher QLS and SWN-S total scores indicate clinical improvements, whereas lower CGI-S, IAQ, CGI-I, WoRQ, and TooL scores indicate better clinical condition.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close